Evidence method
Level · gp.fundamentals.capex_revenue_ratio
-0.83% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TLSI · Jun 30, 2025
TriSalus Life Sciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001826667-25-000117General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-65.28% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
33.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
83.93% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-65.39% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
34.99% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
16.87% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Dec 31, 20240/8 normalizedAmended as filedJun 30, 20250/7 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20250/8 normalizedLevel 3Mar 31, 20260/8 normalizedLevel 3Jun 30, 20260/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 1.17%
- Current
- -0.83%
- Delta
- -2.00%
- Previous
- -138.78%
- Current
- -65.28%
- Delta
- 73.49%
- Previous
- 13.75%
- Current
- 33.95%
- Delta
- 20.20%
- Previous
- 86.06%
- Current
- 83.93%
- Delta
- -2.13%
- Previous
- -122.88%
- Current
- -65.39%
- Delta
- 57.49%
- Previous
- 60.10%
- Current
- 34.99%
- Delta
- -25.11%
- Previous
- 18.49%
- Current
- 16.87%
- Delta
- -1.61%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TLSI Fundamental State →Has State · TriSalus Life Sciences, Inc. →Transitioned To · TLSI Fundamental State →Transitioned To · TLSI CAPEX_INTENSITY_DECREASED →Transitioned To · TLSI CASH_GENERATION_INCREASED →Transitioned To · TLSI INVENTORY_PRESSURE_INCREASED →Transitioned To · TLSI MARGIN_DECREASED →Transitioned To · TLSI PROFITABILITY_INCREASED →Transitioned To · TLSI R_AND_D_INTENSITY_DECREASED →Transitioned To · TLSI SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.